Ankara University Faculty of Medicine
Ankara, Turkey (Türkiye)
NCT Number: NCT05504993
INTRODUCTION: Relationship between comorbidities and COPD is two-sided. While the number of comorbidities increasing, the frequency of acute exacerbations of COPD (AECOPD) is increasing, too. Comorbidity indexes can be used for recognition of comorbidities while managing COPD patients. In the present study, it is aimed to compare comorbidity indexes such as Charlson Comorbidity Index, COMCOLD and COTE in the matter of exacerbation frequency.
METHOD: Subjects hospitalized for AECOPD, admitted to the study. Exacerbation severity, frequency, further exacerbations for a 1-year period in the follow-up period and CCI, COMCOLD and COTE scores were recorded. High and low comorbidity groups were compared for AECOPD frequency, severity, and further exacerbations.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Ankara, Turkey (Türkiye)
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
No intervention has been applied. 92 COPD patients divided into 2 groups according to their comorbidity level. Than these groups were compared for their AECOPD frequency
Time frame: 1 year
Frequency of AECOPD in the last one year
Time frame: 1 year
having at least one severe AECOPD in the last year
Time frame: 1 year
the number of AECOPD for 1 year period from the preceding admission, regardless of severity
Ankara University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06582082
Chronic Disease, Chronic Obstructive Lung Disease
Cairo, Egypt
View Trial DetailsNCT00136006
Chronic Disease, Chronic Obstructive Lung Disease
Vancouver, British Columbia, Canada
View Trial DetailsNCT05838911
Chronic Disease, Chronic Obstructive Lung Disease
Qina, Egypt
View Trial DetailsNCT00814203
Chronic Disease, Chronic Obstructive Lung Disease
Columbus, Ohio, United States
View Trial Details